Morphea
☆ AI Dermatology — Free Service
U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
U rezultatima Stiftung Warentest-a za 2022. iz Njemačke, zadovoljstvo potrošača ModelDerm-om bilo je samo nešto niže nego s plaćenim telemedicinskim konsultacijama.
Lezija morphea obično se pojavljuje kao atrofična i pigmentirana mrlja.
relevance score : -100.0%
ReferencesScleroderma je rijetka bolest koja zahvaća vezivno tkivo, manifestira se kao otvrdnuta koža i ponekad pogađa druge dijelove tijela. Postoje dvije glavne vrste: systemic sclerosis, koja uključuje otvrdnjavanje kože i unutrašnjih organa, i localized scleroderma, također poznat kao morphea, koji obično ostaje ograničen na kožu i tkiva ispod nje, s benignim i samoograničavajućim tokom. Iako je localized scleroderma neuobičajena i njen uzrok nije jasan, nedavna istraživanja sugeriraju da također može utjecati na unutrašnje organe i dovesti do različitih zdravstvenih problema. Rano liječenje je ključno za sprječavanje komplikacija, s obzirom na potencijalnu ozbiljnost localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea (lokalizirana sklerodermija) je rijetka autoimuna bolest koja zahvaća vezivno tkivo. Može se pojaviti na različite načine i nije baš uobičajena, s oko 0,4–2,7 slučaja na 100.000 ljudi godišnje. Morphea se često javlja kod djece uzrasta od 2 do 14 godina, a češće pogađa djevojčice nego dječake.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea je veoma retka bolest. Zbog kompozicije fotografije, algoritam ju je možda zamijenio s morphea.